Michael L. Goldman is a partner and registered patent attorney in the Health Sciences Department of Pepper Hamilton. Mr. Goldman focuses his practice on patent and trademark work and is experienced in all aspects of litigation for patent, trademark, trade dress and trade secret cases, as well as patent and trademark prosecution, agreements and client counseling.
Mr. Goldman has extensive experience handling biotechnology patent matters and represents corporate, academic and other institutional clients on patent prosecution, patent interferences, licenses and other agreements, and opinions. He prosecutes patent applications on a variety of pharmaceutical and biotechnology matters. His patent work in these industries has included DNA diagnostics, immunoassays, allergy medications, inhibitors of fibroproliferative disorders, vaccines, genomics, DNA molecules from pathogens of human and plants, transgenic plants, and cell separation. Additionally, he advises clients in these industries on licenses, material transfer agreements, sponsored research agreements and other contracts.
Alison L. McCarthy is of counsel with Pepper Hamilton, resident in the Boston office. Ms. McCarthy practices in the Intellectual Property Department, where she is primarily focused on patent litigation. Specifically, she routinely handles many aspects of patent litigation, from discovery disputes, to claim construction briefing and hearings, to trial. Ms. McCarthy has participated in two trials before the International Trade Commission representing plaintiffs in patent-based Section 337 investigations. She also prosecutes patent applications in the high-tech arena and handles various aspects of IP due diligence and licensing.
With respect to IP diligence, Ms. McCarthy has conducted in-depth reviews of patent portfolios for companies wishing to maximize the value of their portfolios, whether by asserting existing patent rights, or for the purpose of selling patents and portfolios to other parties.
John P. Isacson is a partner in the Intellectual Property Department of Pepper Hamilton, resident in the Washington, D.C. office. Mr. Isacson focuses on representing clients in the pharmaceutical, biotechnology, chemical and medical device industries in all patent-related matters. His clients include internationally recognized research and health care institutions, emerging ventures, investors and large public corporations.
Mr. Isacson has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, matters involving biosimilar products, and Hatch-Waxman issues. He is regularly involved in litigation, arbitrations and U.S. Patent and Trademark Office and International Trade Commission proceedings. He has also advised on related FDA matters for certain technologies.
Edwin V. (Ted) Merkel is of counsel and a registered patent attorney in the Health Sciences Department of Pepper Hamilton LLP, resident in the Rochester office. Mr. Merkel has more than 20 years of patent prosecution experience, with an emphasis on biotechnology and the chemical arts. His prosecution experience encompasses the procurement of patents in the United States and abroad, representing universities, privately held companies and publicly traded companies.
Mr. Merkel has also been involved in more than ten inter partes review (IPR) proceedings, representing both petitioners and patent owners. His representative IPR proceedings include those involving compositions of matter as well as e-medicine methods and methods for propagating MIMO signals. In this capacity, Mr. Merkel has handled oral arguments before the Patent Trial and Appeal Board.